Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FX2AD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,569
Award facts
- Contract value 100% obligated
- $24,568.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The contract, valued at $24,568.74 with an ultimate completion date of August 14, 2025, was issued without a set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group is a well-established federal contractor that has demonstrated consistent success in supplying specialty medications and biologics to Department of Defense healthcare systems. As a registered small business in SAM.gov since 2001, the company has built a robust portfolio of pharmaceutical deliveries encompassing oncology treatments, immunotherapies, vaccines, and other critical medical supplies. The Keytruda procurement reflects the contractor's core capabilities in distributing branded pharmaceutical products directly to military health facilities, contributing to the DLA's mission of ensuring reliable pharmaceutical supply chains across the Defense Department.
Quick answers
Who was awarded contract SPE2DB25FX2AD?
SPE2DB25FX2AD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FX2AD worth?
The government has obligated $24,569 on SPE2DB25FX2AD.
Is contract SPE2DB25FX2AD an order under another contract?
Yes. SPE2DB25FX2AD is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2AD competed?
The extent of competition for SPE2DB25FX2AD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award